News | Radial Access | February 22, 2017

Radial Access, Same-Day Cardiac Procedure Could Save $300 Million Annually

Procedure also results in fewer health complications as compared to other options

transradial approach, same-day cardiac procedures, radial access, $300 million annual savings, JACC Cardiovascular Interventions study

February 22, 2017 — If hospitals can perform more transradial, same-day percutaneous coronary intervention (PCI), hospitals across the U.S. could collectively save $300 million each year, according to research published recently in JACC: Cardiovascular Interventions. The procedure is also better for patients as it results in fewer health complications.

Currently, balloon angioplasty and stenting are some of the leading national expenditures for cardiovascular procedures. PCI costs the U.S. approximately $10 billion each year. There has been little data on strategies that can be implemented to help reduce costs of PCI.

“We now have identified a mechanism for hospitals to improve their efficiency and lower costs, and which is associated with improved PCI outcomes simultaneously,” said the study’s lead author Amit P. Amin, M.D., MSc, assistant professor of medicine at Washington University School of Medicine in St. Louis. “Our data show there is a tremendous potential to reduce costs of PCI, reduce complications and achieve a ‘win-win’ for both patients and hospitals. Hospitals that redesign their care pathways to perform more same-day, transradial PCIs can potentially save hundreds of thousands of dollars each year.”

The study evaluated different PCI approaches and care pathways to see which would be least costly. Researchers examined nearly 280,000 Medicare patients in the National Cardiovascular Data Registry’s (NCDR) CathPCI Registry undergoing PCI who were eligible for same-day discharge. Out of this group, the arm artery access was used in 9 percent of the patients, and same-day discharge was used in 5.3 percent of patients. The adjusted cost associated with arm access with same-day discharge was $13,389 while the cost associated with leg access with overnight stay was $17,076, a difference of $3,689 per PCI procedure.

The study goes on to point out that by shifting practice by 30 percent for more same-day arm access procedures, a hospital performing 1,000 elective PCI procedures per year could reduce costs by approximately $1 million. If collectively all hospitals across the country followed this care pathway, PCI costs would be lowered by almost $300 million annually.

“One hope is that professional medical organizations will take these findings into account when developing new PCI treatment guidelines, and consider the benefits for both the patient and the health care system as a whole,” Amin said. “Also, we need to continue to pursue research like this — in all areas of medicine — that demonstrates ways in which higher quality care can be delivered at a lower cost, to elevate the value of health care that our patients deserve.”

While selection bias can never be completely ruled out with registry-based outcomes research, every possible attempt to reduce this bias through appropriate exclusions and statistical methodology was made to ensure that the study population was eligible for same day discharge, according to the authors.

Read the article “Radial Access Adoption in the United States.”

Watch the VIDEO “Update on U.S. Transradial Access Adoption With Sunil Rao at TCT 2015”

 

Related NCDR CathPCI Registry articles:

• New Report Highlights National Trends in Heart Disease Treatments

• Better Prognosis for Some PCI Patients When Operators Perform More Procedures

• Study Finds Significant Variability in Doctors' Angioplasty Death Rates

 

Reference

Amin, A.P., Patterson, M., House, J.A., Giersiefen, H., et al. "Costs Associated With Access Site and Same-Day Discharge Among Medicare Beneficiaries Undergoing Percutaneous Coronary Intervention: An Evaluation of the Current Percutaneous Coronary Intervention Care Pathways in the United States," JACC: Cardiovascular Interventions. Published online ahead of print  Feb. 20, 2017. DOI: 10.1016/j.jcin.2016.11.049

Related Content

DISRUPT BTK Study Shows Positive Results With Lithoplasty in Calcified Lesions Below the Knee
News | Peripheral Artery Disease (PAD)| September 20, 2017
Shockwave Medical reported positive results from the DISRUPT BTK Study, which were presented at the annual...
Corindus Announces First Patient Enrolled in PRECISION GRX Registry
News | Robotic Systems| September 18, 2017
September 18, 2017 — Corindus Vascular Robotics Inc.
Two-Year ILLUMENATE Trial Data Demonstrate Efficacy of Stellarex Drug-Coated Balloon
News | Drug-Eluting Balloons| September 18, 2017
Philips announced the two-year results from the ILLUMENATE European randomized clinical trial (EU RCT) demonstrating...
Sentinel Cerebral Protection System Significantly Reduces Stroke and Mortality in TAVR
News | Embolic Protection Devices| September 18, 2017
September 18, 2017 – Claret Medical announced publication of a new study in the...
Fysicon Receives FDA Approval for QMAPP Hemodynamic Monitoring System
Technology | Hemodynamic Monitoring Systems| September 18, 2017
Fysicon announced that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its...
Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Feature | Cath Lab| September 14, 2017
September 14, 2017 — Here are quick summaries for all the key late-breaking vascular and endovascular clinical trials
Mississippi Surgical and Vascular Center Uses Toshiba Ultimax-i FPD to Save Patients' Limbs
News | Angiography| September 14, 2017
The southern U.S. sees some of the highest numbers of chronic medical conditions, such as peripheral artery disease...
Sponsored Content | Videos | Structural Heart Occluders| September 13, 2017
Ziyad Hijazi, M.D., MPH, MSCAI, FACC, director of the cardiac program and chair of the Department of Pediatrics at Si
Philips Showcases Integrated Vascular Solutions at VIVA 2017
News | Peripheral Artery Disease (PAD)| September 13, 2017
Philips announced its presence at the Vascular Interventional Advances (VIVA 17) Annual Conference in Las Vegas from...
Medtronic Announces Japanese Regulatory Approval for In.Pact Admiral Drug-Coated Balloon
News | Drug-Eluting Balloons| September 13, 2017
Medtronic plc announced that the In.Pact Admiral Drug-Coated Balloon (DCB) received approval from the Japanese Ministry...
Overlay Init